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Enzyme promiscuity is a concept that in the last years is earning 
prominence in different fields of enzymology like biocatalysis, 
enzyme engineering or enzyme evolution.[1] Catalytic promiscuity 
is defined as the ability of an enzyme to catalyze more than one 
chemical transformation.[1b,c] Naturally occurring catalytic 
promiscuity provide the starting point for a Darwinian evolution of 
enzymes to new functions since this process must occur 
gradually, while maintaining organism fitness throughout.[2] Tawfik 
and co-workers[3] have provided experimental evidence for the 
plasticity and “evolvability”[4] of promiscuous functions. These 
authors propose a model by which a protein acquires a new 
function, without losing the original one, and gene duplication 
may follow the emergence of a new function, rather than initiate it. 
Besides the intriguing implications that this theory of divergent 
molecular evolution has for protein evolution, its application to 
promiscuous enzymes allows to design enzymes with new 
catalytic activities.[5] 
A special case of catalytic promiscuity is the shown by 
metalloenzymes, where the variety of metallic ions that can be 
incorporated in the active site increase the range of chemical 
transformations that can be catalyzed by the enzyme. Thus, there 
are several examples showing that protein modification via the 
covalent attachment of ligands that incorporate metal ions or by 
incorporation of the catalytic metal ion alone in a suitable site for 
coordination, is a strategy that allows to obtain enzymes with 
either modified or completely new catalytic activities.[6] 
In this communication we describe the promiscuous 
behaviour of the dihydroxyacetone (DHA) kinase from Citrobacter 
freundii strain CECT 4626. This ATP-dependent DHAK is able to 
catalyse, beside the transfer of the γ-phosphate of the ATP to 
DHA, the cyclization of the FAD to yield riboflavin 4’,5’-cyclic 
phosphate (4’,5’-cFMN) (Scheme 1). This catalytic promiscuity is 
modulated by the divalent cation that forms the complex with the 
phosphorylated substrate. 
 
Scheme 1. Natural and promiscuous reactions catalysed by the DHAK from C. 
freundii CECT 4626. The different chemical reactions catalysed by this enzyme 
are indicated by the corresponding EC numbers. 
Although DHAK’s are widely distributed in the three biological 
kingdoms, only their role in the catabolism of glycerol and in 
methanol assimilation in microorganisms have been well 
characterized.[7] In the bacteria C. freundii strain DSM 30040[8] the 
entire dha regulon has been cloned and characterized at 
molecular level.[9] The kinetic properties and mechanism of the 
corresponding DHAK have been described[10] and the X-ray 
structure of the full-length DHAK in complex with its substrates 
has been elucidated.[11] This kinase is the only one known with an 
all-α nucleotide-binding domain.[12] 
From a biocatalytic point of view, ATP-dependent DHAK’s 
have been given considerable attention because their feasibility 
for the simple and efficient obtaining of DHAP.[13] We have 
reported a multi-enzyme system for one-pot C-C bond formation 
catalysed by DHAP-dependent aldolases, based in the use of the 
recombinant DHAK from C. freundii CECT 4626, for in situ DHAP 
formation.[14] This enzyme (GeneBank Accession Nº DQ473522) 
is a new isoform that differs in 22 aa from the enzyme of the DSM 
30040 strain (see the Supporting Information). 
During the progress of our own work towards the biochemical 
characterization of this enzyme, Cameselle and co-workers 
reported the molecular identity of recombinant human and rat 
liver purified FAD-AMP lyase (FMN cyclase) as ATP-dependent 
DHAK’s.[15] These authors had previously published a series of 
papers in which they identified and characterized this Mn2+-
dependent cyclase activity as the only enzymatic source of 
riboflavin 4’,5’-phosphate (cFMN).[16] Human FMN cyclase 
displays 39.4% sequence identity with the DHAK from C. freundii 
CECT 4626. Thus, we decided to study if the DHAK displayed as 
well FMN cyclase activity (Scheme 2). 
The time course of the reaction catalysed by DHAK in 
presence of FAD and Mn2+ was followed by HPLC (see the 
Supporting Information). Chromatograms recorded at different 
reaction times shown that the decrease of the FAD peak was 
concomitant with the apparition of a new peak which retention 
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time was coincident with the previously described for the 
cFMN.[16] 
 
Scheme 2. Promiscous reaction catalysed by DHAK from C. freundii CECT 
4626 in presence of Mn2+. 
This peak was purified and its identity unequivocally assigned 
by NMR and ESI-MS (see the Supporting Information). Thus, we 
were in presence of an enzyme able to catalyse two different 
reactions which were modulated by the divalent ion used as 
cofactor. 
The different kinetic parameters for both reactions and for the 
different substrates are summarized in Table 1. The catalytic 
efficiency (kcat/KM) of DHAK for the different phosphorylated 
substrates was of the same order of magnitude (Table 1). 
Table 1. Summary of the kinetic constants of DHAK from C. freundii CECT 
4626 for the natural and promiscuous activities.[a] 
Activity Substrate KM (mM) kcat (s-1) kcat/KM (s-1/M) 
Kinase DHA 0.0012 24.13 1.98x107 
Kinase Mg-ATP 0.35 24.02 6.9x104 
Kinase Mn-ATP 0.65 24.84 3.8x104 
Cyclase Mn-FAD 0.017 0.47 2.8x104 
[a] Kinetic parameters calculated at 25 ºC 
However, the kinase and cyclase specific activities are 
drastically affected by the Me2+ used as cofactor (Figure 1). 
Meanwhile the kinase activity is almost independent of the 
Me2+, the cyclase activity increase almost 50 times when the 
cofactor used was Mn2+. 
 
Figure 1. Specific activities (U/mg) for the natural and promiscuous reactions 
catalysed by DHAK in presence of Mg2+ or Mn2+. Activities were measured at 25 
ºC with 12 mM of Me2+. In the kinase reaction with Mn2+, 1.35 mM of Me2+ was 
used to avoid inhibition by manganese excess (see Figure 2). 
A detailed analysis of the behaviour of the two activities as 
function of the Mn2+ concentration showed that at low 
concentrations, the DHAK is able to catalyse both, the 
phosphorylation of DHA and the cyclization of the FAD (Figure 2). 
However, from a concentration of Mn2+ about 1.5 mM, the kinase 
activity begins to be inhibited while the cyclase activity reaches 
the saturation without detecting inhibition by effect of Mn2+. 
Although, 1.5 mM is a concentration of manganese much more 
higher than the intracellular concentration of 10 μM usually 
assumed in the literature,[17] the Mn2+ uptake systems of 
Enterobacteria can increase the cytoplasmic concentration of 
Mn2+ over at least two orders of magnitude up to 1-3 mM on a 
time scale as short as a minute.[17,18] Therefore, the cytoplasmic 
concentration of Mn2+ could act as a real switch that turn the 
kinase activity off when the cyclase activity raises the maximum. 
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Figure 2. Natural and promiscuous activities catalysed by DHAK as function of 
Mn2+ concentration. (●) Kinase activity; (○) cyclase activity. Relative activities 
(Vrel) are represented for an easier comparison. 
It seems to be logical to assume that the promiscuous 
activities may occur in the ATP binding site of DHAK, owing to the 
structural similarities between ATP and FAD. To corroborate this 
hypothesis, we performed a series of inhibition and docking 
studies (see the Supporting Information). 
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The results summarized in Table 2, shown that FAD and ATP 
are competing by the same binding site since ATP is a strong 
competitive inhibitor of the cyclase activity, meanwhile DHA is a 
poor uncompetitive inhibitor. Furthermore, AMP, which moiety is 
shared by both ATP and FAD, it is a competitive inhibitor of both 
activities. 
Table 2. DHAK inhibition studies 
 Inhibitor 
Type of inhibition[a] (ki mM) 
Activity/substrate DHA ATP FAD AMP 
Kinase/Mg-ATP N.I — — C.I (10.2) 
Kinase/Mn-ATP N.I — 
M.I 
(kic=0.5) 
(kiu=3.0) 
C.I 
(71.8) 
Cyclase/Mn-FAD U.I (576) 
C.I 
(0.2x10-3) — 
C.I 
(3.52) 
[a] C.I=competitive inhibition; U.I=uncompetitive inhibition; M.I=mixed inhibition; 
N.I=no inhibition. 
On the other hand, the behaviour of the FAD as inhibitor was 
more complex since it showed a mixed inhibition pattern which 
competitive component was higher than the uncompetitive one 
(Figure 3). 
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Figure 3. (A) Hanes-Woolf plot from DHAK kinetics in presence of several FAD 
concentrations. (B) and (C) are secondary plots used to calculate kiu and kic. 
This behaviour could be explained if FAD is bound to the 
active centre in two sub-sites, one of them coincident with the 
ATP binding site and the other probably related with the bound of 
the isoalloxazine ring of the FAD. This interpretation was 
supported by docking studies.  
Scheme 3 shown the minimized FAD bound in the ATP 
binding site of the DHAK from C. freundii strain DSM 30040 (pdb 
1un9).11 The phosphate groups of FAD are positioned where the 
ATP ones in the crystal structure which are coordinated by two 
Mg2+ with the γ-carboxyl groups of aspartyl residues (Asp380, 
Asp385 and Asp387). Asp385 is at hydrogen bond distance (3.0 
Å) of the –OH 5 involved in the cyclization of FAD.16b Besides 
these residues, Val434 and Gly113, that do not participate in the 
binding of ATP, could be interacting with the isoalloxazine ring of 
the FAD. 
 
Scheme 3. FAD docked into the ATP binding site of DHAK enzyme (stick) from 
C. freundii strain DSM 30040 (pdb 1un9).11 In green are represented the aa that 
interact with both ATP and FAD; in black those that only interact with ATP and 
in red those residues that interact only with the FAD. 
Interestingly, the kinetic parameters of the FMN cyclase 
activity determined for the DHAK from C. freundii CECT 4626 are 
quite different from those reported by Cameselle and co-workers 
for the rat liver enzyme.16b The results summarized in Table 3 
clearly shown that the rat liver enzyme is much more efficient as 
cyclase that the bacterial enzyme. Thus, the kcat/KM value of the 
rat enzyme is more than one order of magnitude higher than the 
value of the C. freundii enzyme. 
Table 3. Kinetic parameters of 4’,5’-cFMN cyclase from C. freundii CECT 4626 
and rat liver. 
DHAK source Specific activity 
(U/mg) 
KM (mM) kcat (s-1) kcat/KM (s-1/M) 
C. freundii 
CECT 4626[a] 
0.5 0.022 0.68 3.1x104 
Rat liver[b] 3.2 0.009 4.82 5.3x105 
[a] Kinetic parameters calculated at 37 ºC for comparison purposes. [b] Data 
taken from reference 16b. 
These results suggested that, in this case promiscuity is 
playing a role in the divergence of a novel enzyme function. 
Based on aminoacid sequence, the DHAK’s from Citrobacter, 
plants and mammals grouped into the same class (Figure 4 and 
reference 7).  
 4
Althought, the relationships between classes as shown by the 
branching order at the centre of this unrooted tree is unreliable, 
evolutionary information can be derived within each class. 
Therefore, our results suggest that enzymes in this separate 
branch has been under a process of divergent molecular 
evolution, along which the promiscuous function acquired higher 
activity and specificity. 
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Figure 4. Unrooted tree showing the sequence relationships between DHAK 
from C. freundii CECT 4626 and DHAK-like proteins in the Swiss-Prot database 
(for details see the Supporting Information). 
In conclusion, we have described the natural promiscuous 
behaviour of the DHAK from Citrobacter freundii CECT 4626. 
This catalytic promiscuity is modulated by the divalent cation that 
forms the complex with the phosphorylated substrate. Through 
kinetic and docking studies we have demonstrated that both 
activities are linked to the same binding site. The present results 
shown that the DHAK plasticity is involved in the adquisition of a 
new catalytic function according to the model proposed by Tawfik 
and others.[2,3] 
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Materials and General Procedures 
 
SDS-PAGE was performed using 10% and 5% acrylamide in the resolving and stacking gels, 
respectively. Gels were stained with Coomassie brilliant blue R-250 (Applichem GmBH, 
Germany). Electrophoresis were always run under reducing conditions, in the presence of 5% β-
mercaptoethanol. Protein and DNA gels were quantified by densitometry. Triosephosphate 
isomerase (TIM) and α-glycerophosphate dehydrogenase (αGDH), were purchased from Sigma-
Aldrich (St. Louis, MO). Restriction enzymes, Taq polymerase and T4-DNA ligase were purchased 
from MBI Fermentas AB (Lithuania). Citrobacter freundii CECT 4626 was provided from the 
Spanish Type Culture Collection (CECT). E. coli BL21(DE3) competent cells were purchased from 
Stratagene Co. (San Diego, CA). PCR primers were purchased from Isogen Life Science (Spain) 
and the pRSET-A expression vector was purchased from Invitrogen Co. (Carlsbad, CA). Isopropyl-
β-d-thiogalactopyranoside (IPTG) was purchased from Applichem GmBH (Germany). Plasmids 
and PCR purification kits were from Promega (Madison, WI) and DNA purification kit from 
agarose gels was from Eppendorf (Hamburg, Germany). Nickel-iminodiacetic acid (Ni2+-IDA) 
agarose was supplied by Agarose Bead Technologies (Spain). All other chemicals were purchased 
from commercial sources as reagent grade. 
 
Cloning, overexpression and purification of DHAK from C. freundii CECT 4626 
 
DNA manipulation was according to standard procedures (Sambrook et al. 1989). DNA template 
for amplification of the dhak gene was obtained from the Citrobacter freundii strain CECT 4626. 
Primers for PCR amplification were designed based on the nucleotide sequence of the dhak gene 
from the strain DSM 30040 (GeneBank Accession Nº U09771). The oligonucleotides 5´-
ATATTAAGCTTCAAAACATTACTCAG-3´ and 5´-
TATTACTCGAGTTACAGCCAGCGCACTGGC-3´ were used as leftward and rightward primers 
respectively (the recognition sequence for HindIII and XhoI are underlined). PCR amplification was 
performed in a 100 μl reaction mixture and subjected to 30 cycles of amplification. The cycle 
conditions were set as follows: denaturation at 94ºC for 1 min, annealing at 55 ºC for 1 min and 
elongation at 72 ºC for 1.5 min. The purified PCR product was digested with XhoI and HindIII and 
ligated into the doubled digested vector pRSET-A to yield the plasmid pRSET-dhak. This plasmid 
was transformed into E. coli BL21(DE3) competent cells. 
A colony containing the plasmid pRSET-dhak was cultured in Luria-Bertani (LB) broth containing 
ampicillin (250 μg/ml) at 37 ºC with shaking. When the culture reached an O.D600nm of 0.5-0.6, 
DHAK expression was induced with IPTG (1 mM) and the temperature was dropped to 30 ºC. The 
culture was maintained O/N. After that, the culture was centrifuged at 10,000 x g during 10 min at 4 
ºC and the resulting pellet was treated with lysozyme and DNase for protein extraction.1  
The recombinant protein containing an N-terminal 6xHis tag was purified in a Ni+2-IDA-agarose 
column pre-equilibrated with sodium phosphate buffer (20 mM, pH 7.5). DHAK was eluted with 
the same buffer containing imidazole 0.25 M. All the fractions containing protein were pooled 
together and further purified by size-exclusion chromatography on a HiLoad 26/60 Superdex 75 PG 
column controlled using the AKTA-FPLC system (GE Healthcare Life Science). The column was 
developed in 50 mM phosphate buffer pH 7.2 containing NaCl (0.15 M) at a constant flow rate of 
1.0 ml/min (SFigure 1). 
 
                                                 
1 A. Bastida, A. Fernández-Mayoralas, R. Gómez, F. Iradier, J. C. Carretero, E. García-Junceda, Chem. Eur. J. 2001, 7, 
2390–2397 
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SFigure 1. Purification of the recombinant DHAK. Chromatogram of the size-exclusion step. SDS-PAGE shows: lane 
1, low molecular weight markers; lane 2, cell free extract; lane 3, DHAK after IMAC step; lanes 4-10 fractions 
containing DHAK activity. 
 
Protein analysis 
 
Amino acid analysis of purified DHAK aliquots was performed at the Department of Biochemistry 
and Molecular Biology of the Complutense University of Madrid to determine the protein 
concentration. The absorption spectrum of different quantified samples allowed determination of 
the molar extinction coefficient of DHAK at 280 nm (ε280 = 44432.5 M-1·cm-1). 
Peptide mass fingerprint analysis from the SDS-PAGE band corresponding to the putative 
recombinant DHAK was performed at the Proteomic Unit of the Spanish National Center of 
Biotechnology (Centro Nacional de Biotecnología, CSIC). Samples were digested with sequencing 
grade trypsin overnight at 37ºC. The analysis by MALDI-TOF mass spectrometry produces peptide 
mass fingerprints and the peptides observed can be collated and represented as a list of 
monoisotopic molecular weights. Data were collected in the m/z range of 800-3600. 29 peptides 
covering the major part of the amino acid sequence of the protein were identified (SFigure 2). 
Almost all the predicted tryptic peptides with molecular masses falling in the analyzed m/z range 
were found in the peptide mass fingerprint of the recombinant DHAK. Peptide mass fingerprinting 
verified that purified protein had the expected features of DHAK from C. freundii CECT 4626. 
 
Enzyme activity assays 
 
Phosphorylation of DHA was measured spectrophotometrically in a coupled enzymatic assay based 
in the reduction of DHAP to α-glycerophosphate, catalyzed by αGDH with concomitant oxidation 
of NADH to NAD+. The assays were run at 25 or 37 ºC following the decrease of absorbance at 340 
nm ( 340NADHε = 6220 cm-1·M-1) for 10 minutes in reaction mixtures of 1 ml containing Tris-HCl (40 
mM, pH 8.0), DHA (2.5 μmol), NADH (0.2 μmol), ATP (5.0 μmol), MgSO4 (5.0 μmol), αGDH 
(1.26 U), TIM (12.6 U) and DHAK. One unit of kinase activity was defined as the amount that 
produces 1 μmol of DHAP per min under the above conditions. 
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SFigure 2. Peptide mass fingerprint of DHAK from C. freundii CECT 4626. Sequence of DHAK, indicating the 
theoretical trypsin cleavage sites (?).The sequence of the identified peptides are shaded and underlined when 
overlapping. Molecular mass of each peptide is indicated in Da. Bold-inverted cells indicate the modified aminoacid 
with respect to the sequence of the protein from the strain DSM 30040. 
 
FMN cyclase activity was determined by measuring the formation of 4’,5’-cFMN from FAD by 
HPLC with A430nm monitoring in reaction mixtures of 1 ml containing Tris-HCl (40 mM, pH 7.5),  
MnCl2 (12 mM), FAD (0.25 mM) and DHAK. Full reaction mixtures were incubated from 10 to 60  
min. HPLC was performed in an Inertsil ODS-2 column following the previously described assay  
with minor modifications.2 The mobile phase employed was 20 mM sodium phosphate, pH 6.0, and 
methanol at a final concentration of 35% (v/v) and the chromatography was run under isocratic 
conditions at 1 ml/min flow rate (SFigure 3). One unit of cyclase activity was defined as the amount 
of enzyme that produces 1 μmol of 4’,5’-cFMN per min under the above conditions. 
 
 
t = 0
t = 10
t = 20
t = 30
t = 40
t = 50
t = 60
FAD 
4’,5’-cFMN 
 
 
SFigure 3. HPLC chromatograms of the cyclization reaction catalysed by the DHAK from C. freundii strain CECT 
4626. 
                                                 
2F. J. Fraiz, R. M. Pinto, M. J. Costas, M. Ávalos, J. Canales, A. Cabezas, J. C. Cameselle, Biochem. J. 1998, 330: 881-
888. 
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Steady-state kinetic assays and inhibition studies 
 
Steady-state kinetic assays for kinase activity were measured at 25 ºC in 96-well plates in a total 
volume of 0.3 ml. Measurements of kinetic parameters for DHA were performed with 0.08 μg/ml of 
purified DHAK at ten different DHA concentrations and with saturating concentration of 
[MgATP]2- (5.0 mM) (SFigure 5A). Assays to determine the kinetic parameters for [MgATP]2- 
complex were performed with 1.0 μg/ml of purified DHAK at sixteen concentrations of complex 
using a constants Mg2+ excess of 40 mM and 2.5 mM of DHA (SFigure 5C). Assays to determine 
the kinetic parameters for [MnATP] were performed with 0.9 μg/ml of purified DHAK at twelve 
concentrations of complex using 2.5 mM of DHA (SFigure 5D). In order to avoid Mn2+ excess 
inhibition (see Figure 2) the maximum MnCl2 concentration used was 1.3 mM (7.5 fold lower than 
ATP concentrations in each kinetic point). Cyclase activity was measured at seven FAD 
concentrations in presence of MnCl2 (12 mM) using 4.1 μg/ml of purified DHAK in 25 ºC kinetic 
(SFigure 5B) and 1.7 μg/ml of enzyme in 37 ºC kinetic. 
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SFigure 5. Substrate kinetics of kinase an cyclase activity for DHAK from C. freundii CECT 4626 at 25ºC. Kinase 
activity of purified DHAK was measured at several concentrations of DHA (A), MgATP (C) and MnATP (D) 
maintaining constant excesses of MgATP (A) and DHA (C and D). Cyclase activity or purified DHAK was measured at 
various FAD concentrations in presence of MnCl2 12 mM. The inserts shows Hanes-Woolf plots used for kinetic 
constants determination. 
 
Kinetic constants were obtained using the built-in nonlinear regression tools in SigmaPlot 8.0 and 
by nonlinear regression to the experimental data using the SIMFIT package3 (url: 
                                                 
3 H. G. Holzhütter, A. Colosimo, Bioinformatics 1989, 6, 23-28. 
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http://www.simfit.man.ac.uk). For the determination of apparent kinetic constants (variation of only 
one substrate), initial velocities (Vi) were fitted to the Michaelis-Menten equation 
Inhibition studies were conducted in steady-state kinetic assays for FAD, [MgATP]2- and [MnATP] 
in presence of several concentrations of considered inhibitor (SFigure 6). Inhibition of cyclase 
activity by ATP (SFigure 6A), DHA (SFigure 6B) and AMP (SFigure 6C) were analyzed in FAD 
activity assays in presence of increasing concentrations of inhibitor. Inhibition panther of kinase 
activity by AMP was analyzed using [MgATP]2- (SFigure 6D) and [MnATP] (SFigure 6E) as 
phosphate donors. Inhibition of kinase activity by FAD was analyzed in [MnATP] kinetic with 
increasing concentrations of inhibitor (Figure 3). 
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SFigure 6. Inhibition kinetics for DHAK from C. freundii CECT 4626. (A) Lineweaver-Burk plots from cyclase 
activity at different concentrations of FAD in presence of increasing concentrations of ATP: 30 nM (▼), 100 nM (○) 
and 150 nM (●). (B) Hanes-Woolf plots from cyclase activity at different concentrations of FAD in presence of 
increasing concentrations of DHA: 0 mM (?), 50 mM (●), 100 mM (○) and 200 mM (▼). (C) Lineweaver-Burk plots 
from cyclase activity at different concentrations of FAD in presence of increasing concentrations of AMP: 0 mM (?), 
0.5 mM (●), 2.5 mM (○) and 5.0 mM (▼). (D) Lineweaver-Burk plots from kinase activity at different concentrations 
of MgATP and constant excess of DHA, in presence of increasing concentrations of AMP: 0 mM (♦), 3 mM (●), 6 mM 
(○), 9 mM (▼), 12 mM (?) and 15 mM (■). (E) Lineweaver-Burk plots from kinase activity at different concentrations 
of MnATP and constant excess of DHA, in presence of increasing concentrations of AMP: 5 mM (●), 10 mM (○), 15 
mM (▼), 20 mM (?), 25 mM (■) and 30 mM (□). 
 
NMR procedures. 
 
1H and 13C NMR spectra, using D2O as solvent, were recorded on a Varian SYSTEM 500 
spectrometer equipped with a 5 mm HCN cold probe with field z-gradient, operating at 500.13 and 
125.76 MHz for 1H and 13C, respectively. The sample temperature was maintained constant at 298 
K. One-dimensional NMR experiments were performed using standard Varian pulse sequences. 
Two-dimensional [1H, 1H] NMR experiments (gCOSY and TOCSY) were carried out with the 
following parameters: a delay time of 1 s, a spectral width of 3000 Hz in both dimensions, 4096 
complex points in t2 and 4 transients for each of 256 time increments, and linear prediction to 512. 
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The data were zero-filled to 4096 × 4096 real points. Two-dimensional [1H-13C] NMR experiments 
(gHSQC and gHMBC) used the same 1H spectral window, a 13C spectral windows of 15 000 Hz, 1 s 
of relaxation delay, 1024 data points, and 256 time increments, with a linear prediction to 512. The 
data were zero-filled to 4096 × 4096 real points. Typical numbers of transients per increment were 
4 and 16, respectively. 
 
NMR structural  elucidation 
 
Unequivocal structural elucidation of the purified product was carried out by the combined use of 
1D and 2D  [1H, 1H]  and [1H-13C] NMR experiments (gCOSY, TOCSY, gHSQC and gHMBC). 
The 1H and 13C 1D NMR spectra showed chemical shifts that were consistent with a mixture of two 
compounds in a ratio 4:1 (SFigures 7 and 8). The major compound was identified as riboflavin 4’-5’ 
phosphate (cFMN). The assignment of the 7,8-dimethylisoalloxazine moiety was based on 1D 1H 
NMR and 2D gHSQC and gHMBC. Using the C11 resonance as the starting point, the assignments 
of all protons and carbons of the ribityl chain were obtained easily from gCOSY, gHSQC and 
gHMBC experiments (SFigure 9).  The presence of a measurable 3J(31P,13C) coupling constant for 
C3’ indicated the existence of a cyclic phosphate fragment. NMR relevant data are collected in 
Table 1 showing a good concordance with those published for cFMN. 
 
Table 1. 1H and 13C-NMR relevant data (δ, ppm) in D2O.  
 cFMN AMP 
Position δ 13C δ 1H Position δ 13C δ 1H 
7,8-dimethylisoalloxazine   Adenine   
2 157.8  2  8.00 
4 161.0  4 148.1  
6 130.2 7.46 5 119.1  
7 139.3  6 155.6  
8 150.6  8 140.9 8.12 
9 116.7 7.57  
11 131.4  
12 134.2  
13 149.8  
14 133.8  
CH3(C7) 18.8 2.22 
CH3(C8) 20.7 2.37 
Ribityl Chain   Ribose   
1’ 47.6 4.58 
4.90 
1’ 88.2 5.84 
2’ 69.3 4.12 2’ 73.7 4.56 
3’ 72.5 3.97 3’ 70.5 4.25 
4' 75.2 4.56 4’ 85.7 4.11 
5’ 66.3 4.16 
4.30 
5’ 61.4 3.74 
3.66 
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SFigure 7 1H NMR (500MHz, D2O) spectrum of riboflavin 4’-5’ phosphate (cFMN). 
 *  M
inor com
pound resonances. 
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SFigure 8 13C NMR (125MHz, D. I2O) spectrum of riboflavin 4’-5’ phosphate (cFMN). 
 *  M
inor com
pound resonances. I  Im
purities 
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Finally, the structure elucidation of the minor compound was carried out. Two aromatic singlets at 
8.00 and 8.12 ppm and an anomeric doublet at 5.84 ppm were observed in the 1H spectrum. Only 
sugar carbons were observed in the 1D 13C spectrum. However, from gCOSY, gHSQC and gHMBC 
experiments (SFigure 9B) the assignment of NMR spectra was possible (Table 1). So, the minor 
compound was identified as adenosine 5'-phosphate (AMP). 
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SFigure 9. Relevant observed [1H-13C] gHMBC  correlations (blue) and [1H-31P] gHMBC (red) for major and minor 
compounds. A:  Riboflavin 4’-5’ phosphate (cFMN).B:  Adenosine monophosphate (AMP). 
 
Molecular docking studies 
 
Docking simulation was conducted with AutoDock 3.0.44 which is a fully automated docking suited 
of programs, which employs a genetic algorithm (GA) as a search engine. The coordinates of the 
protein (1un9)5 were taken from the Protein Data Bank. Before docking, compounds were 
minimised by Molecular mechanics (PM3) using MM3* force fields. Protein was prepared by 
eliminating heteroatoms and adding the hydrogen atoms (polar only). Polar hydrogen atoms and 
Gagsteir-Huckel were added to the compounds by using the auxiliary program AutoDock Tools 
(ADT). Energies were evaluated from recalculated potentials grids with molecular affinity 
potentials. Affinity grid files were generated using the auxiliary program Autogrid. The centers of 
the coordinates of the ligands were taken as the centers of the grids, and the dimensions of the grids 
were 76/63/123 for the FAD with points separated by 0.37 Å. After docking, the 50 solutions were 
clustered into groups with RMS deviations of 1 Å. The FAD conformers were bound to the ATP-
binding domain of the enzyme (L-domain; Sfigure 10). The optimal docked conformer was to the 
global minimum giving docked energy of -5.38 Kcal/mol 
 
                                                 
4 G. M. Morris, D. S. Goodsell, R. S. Halliday, R. Huey, W. E. Hart, R. K. Belew, A. J. Olson, J. Comput. Chem. 1998, 
19. 1639-1662. 
5 C. Siebold, I. Arnold, L. F. García-Alles, U. Baumann, B. Erni, J. Biol. Chem. 2003, 278, 48236-48244. 
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SFigure 10. 3D structure of the dimeric DHAK from C. freundii DSM 30040.4 In the N-terminal domain —K-domain 
(blue)— is where the DHA (purple) binding site is located. The ATP (dark blue) binding site is found in the C-terminal 
—L-domain (pink). In yellow are shown the amino acids in which differ the DSM 30040 isoform from the CECT 4626 
isoform. 
 
Sequence similarity searching and phylogenetic tree analysis 
 
A similarity search for the DHAK from C. freundii CECT 4626 (GeneBank Accession Nº 
DQ473522) was performed by BLASTP6 on the NCBI non-redundant SwissProt database using 
default settings. 30 proteins sequences with significant similarity were identified and analysed by 
BLAST pairwise alignment. The 17 proteins showing a maximum sequence differences below 0.75 
were considered to build a matrix of distance according to the Kimura method.7 Subsequently, the 
unrooted tree was derived by the Fast Minimum Evolution method,8 as implemented at the NCBI 
server. 
 
                                                 
6 a) S. F. Altschul, T. L. Madden, A. A. Schäffer, J. Zhang, Z. Zhang, W. Miller, D. J. Lipman Nucleic Acids Res. 1997, 
25, 3389-3402; b) S. F. Altschul, J. C. Wootton, E. M. Gertz, R. Agarwala, A. Morgulis, A. A. Schäffer, Y.-K. Yu 
FEBS J. 2005, 272, 5101-5109. 
7 M. Kimura, J. Mol. Evol. 1980, 16, 111-120. 
8 R. Desper, O. Gascuel, J. Comput. Biol. 2002, 9, 687-705. 
